Providing safe care for patients in the coronavirus disease 2019 (COVID-19) era: A case series evaluating risk for hospital-associated COVID-19

被引:5
|
作者
Habermann, Elizabeth B. [1 ]
Tande, Aaron J. [2 ]
Pollock, Benjamin D. [3 ]
Neville, Matthew R. [3 ]
Ting, Henry H. [1 ,2 ,3 ,4 ]
Sampathkumar, Priya
机构
[1] Mayo Clin, Div Hlth Care Delivery Res, Rochester, MN 55902 USA
[2] Mayo Clin, Div Infect Dis, Rochester, MN USA
[3] Mayo Clin, Dept Qual Experience & Affordabil, Rochester, MN USA
[4] Mayo Clin, Dept Cardiovasc Med, Jacksonville, FL USA
来源
关键词
D O I
10.1017/ice.2021.38
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: We evaluated the risk of patients contracting coronavirus disease 2019 (COVID-19) during their hospital stay to inform the safety of hospitalization for a non-COVID-19 indication during this pandemic. Methods: A case series of adult patients hospitalized for 2 or more nights from May 15 to June 15, 2020 at large tertiary-care hospital in the midwestern United States was reviewed. All patients were screened at admission with the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) polymerase chain reaction (PCR) test. Selected adult patients were also tested by IgG serology. After dismissal, patients with negative serology and PCR at admission were asked to undergo repeat serologic testing at 14-21 days after discharge. The primary outcome was healthcare-associated COVID-19 defined as a new positive SARS-CoV-2 PCR test on or after day 4 of hospital stay or within 7 days of hospital dismissal, or seroconversion in patients previously established as seronegative. Results: Of the 2,068 eligible adult patients, 1,778 (86.0%) completed admission PCR testing, while 1,339 (64.7%) also completed admission serology testing. Of the 1,310 (97.8%) who were both PCR and seronegative, 445 (34.0%) repeated postdischarge serology testing. No healthcare-associated COVID-19 cases were detected during the study period. Of 1,310 eligible PCR and seronegative adults, no patients tested PCR positive during hospital admission (95% confidence interval [CI], 0.0%-0.3%). Of the 445 (34.0%) who completed postdischarge serology testing, no patients seroconverted (0.0%; 95% CI, 0.0%-0.9%). Conclusion: We found low likelihood of hospital-associated COVID-19 with strict adherence to universal masking, physical distancing, and hand hygiene along with limited visitors and screening of admissions with PCR.
引用
收藏
页码:1479 / 1485
页数:7
相关论文
共 50 条
  • [41] Risk of coronavirus disease 2019 (COVID-19) from hospital admission during the pandemic
    Nalleballe, Krishna
    Siddamreddy, Suman
    Kovvuru, Sukanthi
    Veerapaneni, Poornachand
    Roy, Bhaskar
    Onteddu, Sanjeeva Reddy
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (10): : 1285 - 1286
  • [42] A Review on Coronavirus Disease 2019 (COVID-19) in Pediatric Patients
    Moghadam, Solmaz Ohadian
    Afshar, Davoud
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2020, 8 (03): : 1 - 9
  • [43] Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients
    Cheruiyot, Isaac
    Sehmi, Prabjot
    Ominde, Beryl
    Bundi, Paul
    Mislani, Musa
    Ngure, Brian
    Olabu, Beda
    Ogeng'o, Julius A.
    NEUROLOGICAL SCIENCES, 2021, 42 (01) : 25 - 33
  • [44] Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
    Zha, Lei
    Li, Shirong
    Pan, Lingling
    Tefsen, Boris
    Li, Yeshan
    French, Neil
    Chen, Liyun
    Yang, Gang
    Villanueva, Elmer V.
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (09) : 416 - 420
  • [45] Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients
    Isaac Cheruiyot
    Prabjot Sehmi
    Beryl Ominde
    Paul Bundi
    Musa Mislani
    Brian Ngure
    Beda Olabu
    Julius A. Ogeng’o
    Neurological Sciences, 2021, 42 : 25 - 33
  • [46] Asymptomatic coronavirus disease 2019 (COVID-19) in hospitalized patients
    Passarelli, Victor C.
    Faico-Filho, Klinger
    Moreira, Luiz V. L.
    Luna, Luciano Kleber de Souza
    Conte, Danielle D.
    Camargo, Clarice
    Perosa, Ana H.
    Bellei, Nancy
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2021, 42 (09): : 1158 - 1160
  • [47] Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)
    Dong, Xiaotian
    Wang, Mengyan
    Liu, Shuangchun
    Zhu, Jiaqi
    Xu, Yanping
    Cao, Hongcui
    Li, Lanjuan
    AGING AND DISEASE, 2020, 11 (03): : 642 - 648
  • [48] Myocardial Injury in Coronavirus Disease 2019 (COVID-19) Patients
    Aburawi, Elhadi H.
    Alsuwaidi, Ahmed R.
    IBNOSINA JOURNAL OF MEDICINE AND BIOMEDICAL SCIENCES, 2020, 12 (02): : 82 - 84
  • [49] Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19)
    Yang LL
    Yang T
    中华物理医学与康复杂志, 2020, 42 (08) : 733 - 733
  • [50] A coronavirus disease 2019 (COVID-19) outbreak in a hospital and hospital closure: A note
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 (12): : 1475 - 1476